Director Craig Loverock receives 25,002 options at Worksport (WKSP)

Rhea-AI Filing Summary

Worksport Ltd director Craig William Loverock reported receiving stock options on common shares. On February 9, 2026, he was granted 25,002 stock options with an exercise price of $1.66 per share, increasing his directly held derivative position to 61,752 stock options.

The options were granted under Worksport’s 2022 Equity Incentive Plan and vest in three equal annual installments of 8,334 options, beginning on the first anniversary of the grant date, and expire according to the plan and award agreement terms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Loverock Craig William

(Last) (First) (Middle)

2500 N AMERICA DR.

(Street)

WEST SENECA NY 14224

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Worksport Ltd [ WKSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$1.66	02/09/2026		A		25,002		(1)	(1)	Common Stock	25,002	$1.66	61,752	D

Explanation of Responses:

1. Granted pursuant to the Issuer's 2022 Equity Incentive Plan, the options vest in three (3) equal annual installments of 8,334 options beginning on the first anniversary of the grant date and expire in accordance with the terms of the 2022 Equity Incentive Plan and the applicable award agreement.

	/s/ Craig W. Loverock	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Worksport (WKSP) report for Craig Loverock?

Worksport reported that director Craig William Loverock received 25,002 stock options on February 9, 2026, at an exercise price of $1.66 per share. These options were granted under the company’s 2022 Equity Incentive Plan as part of his equity compensation.

How many Worksport stock options does Craig Loverock hold after this grant?

After the February 9, 2026 grant, Craig William Loverock beneficially owns 61,752 Worksport stock options directly. This total reflects the newly granted 25,002 options added to his previously held derivative securities, as reported in the Form 4 filing.

What is the exercise price of Craig Loverock’s new Worksport stock options?

The newly granted Worksport stock options to director Craig William Loverock have an exercise price of $1.66 per share. This means he can purchase Worksport common stock at $1.66 once the options vest and while they remain outstanding.

How do Craig Loverock’s Worksport options vest under the 2022 Equity Incentive Plan?

Craig Loverock’s 25,002 Worksport stock options vest in three equal annual installments of 8,334 options. Vesting begins on the first anniversary of the February 9, 2026 grant date and follows the terms of the 2022 Equity Incentive Plan and award agreement.

What plan governs the stock options granted to Craig Loverock at Worksport?

The stock options granted to Craig William Loverock are issued under Worksport’s 2022 Equity Incentive Plan. The plan sets key terms such as vesting schedule, expiration conditions, and other award provisions referenced in the Form 4 footnote.